Health Catalyst (NASDAQ:HCAT) CEO Buys 59,000 Shares of Stock

Key Points

• Health Catalyst CEO Simeon Kohl purchased 59,000 shares at an average price of $1.79, investing $105,610 and increasing his direct ownership by 2.11% to 2,856,385 shares.
• Health Catalyst shares recently traded at $1.73, with a market capitalization of about $130.2 million and a 52-week range of $0.96 to $3.62.
• The company exceeded quarterly earnings and revenue expectations, but analysts remain cautious: the stock carries a consensus “Hold” rating with an average price target of $2.45, while Health Catalyst continues to report significant net losses.

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) CEO Simeon Kohl bought 59,000 shares of the company's stock in a transaction on Monday, September 14th. The stock was bought at an average price of $1.79 per share, for a total transaction of $105,610.00. Following the completion of the purchase, the chief executive officer directly owned 2,856,385 shares in the company, valued at approximately $5,112,929.15. This represents a 2.11% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

Health Catalyst Trading Up 0.6%

Shares of Health Catalyst stock traded up $0.01 on Wednesday, hitting $1.73. 337,743 shares of the company traded hands, compared to its average volume of 1,042,756. The stock's 50 day moving average price is $1.91 and its 200-day moving average price is $1.64. The company has a current ratio of 2.70, a quick ratio of 2.70 and a debt-to-equity ratio of 1.51. Health Catalyst, Inc. has a 52 week low of $0.96 and a 52 week high of $3.62. The company has a market cap of $130.20 million, a PE ratio of -0.47 and a beta of 1.53.

Health Catalyst (NASDAQ:HCAT - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.01. The company had revenue of $70.49 million for the quarter, compared to analysts' expectations of $69.09 million. Health Catalyst had a negative return on equity of 1.83% and a negative net margin of 90.61%. Equities research analysts predict that Health Catalyst, Inc. will post -0.18 EPS for the current year.

Analyst Ratings Changes

HCAT has been the topic of several research reports. Wells Fargo & Company cut their price target on Health Catalyst from $1.75 to $1.50 and set an "equal weight" rating on the stock in a research note on Thursday, August 13th. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $1.80 price objective (down from $3.00) on shares of Health Catalyst in a research note on Thursday, August 20th. Citigroup cut their target price on shares of Health Catalyst from $2.50 to $2.00 and set a "neutral" rating on the stock in a research report on Tuesday, August 11th. Finally, Weiss Ratings upgraded shares of Health Catalyst from a "sell (e+)" rating to a "sell (d-)" rating in a report on Tuesday, July 28th. Three research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $2.45.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Visionary Wealth Advisors purchased a new stake in shares of Health Catalyst during the 2nd quarter worth $27,000. AXQ Capital LP bought a new stake in Health Catalyst during the second quarter valued at about $38,000. Deutsche Bank AG purchased a new position in Health Catalyst in the second quarter valued at about $43,000. Perigon Wealth Management LLC purchased a new position in Health Catalyst in the second quarter valued at about $77,000. Finally, EP Wealth Advisors LLC bought a new position in Health Catalyst in the second quarter worth about $99,000. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Company Profile

Health Catalyst, Inc is a healthcare technology and data analytics company that helps healthcare organizations use data to improve clinical outcomes, operational performance and financial results. The company provides software, data management capabilities and professional services designed to support hospitals, health systems, medical groups and other healthcare providers.

Its offerings include the Health Catalyst Data Operating System, which integrates and organizes data from disparate clinical, financial and operational systems, as well as analytics applications for areas such as quality improvement, population health, cost management and care delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.